HOME >> BIOLOGY >> NEWS
ASM Biodefense Research Meeting

The American Society for Microbiology (ASM) will host its 2006 Biodefense Research Meeting from February 15-18, 2006 at the Hyatt Regency Washington, DC.

There is a continuing need for research that helps protect the public against not only the traditional agents of bioterrorism, like anthrax, but also against emerging infectious diseases that hold the potential for serious human and economic harm, such as H5N1 influenza.

The purpose of this meeting is to identify existing state-of-the-art research in the biomedical sciences that can be adapted to address biodefense needs. This includes vaccine development and testing, new and faster diagnostics for biothreat agents, and new treatments for potential biowarfare agents. The meeting will also focus on better understanding of potential modes of disease transmission and factor affecting both bacterial and viral virulence.

The first day of the conference will be devoted two concurrent Focus Sessions focusing respectively on microbial forensics and the risk of biothreat agents in our drinking water. These will be followed by the Opening Session which includes a keynote address by Anthony Fauci, Director of the National Institute of Allergy and Infectious Disease.

Additional presentation topics include:

  • New Vaccine Strategies for Biothreat Agents
  • Influenza: Planning for the Next Pandemic
  • Insight into Evolution and Animal Origins of SARS


'"/>

Contact: Jim Sliwa
jsliwa@asmusa.org
202-942-9297
American Society for Microbiology
24-Jan-2006


Page: 1

Related biology news :

1. ASM Biodefense and Emerging Diseases Research Meeting
2. Gilbert Foundation and American Fed for Aging Research award grants on Alzheimers disease
3. Research shows skeleton to be endocrine organ
4. Research aims to identify markers for menopausal women at risk for deadly blood clot
5. Research team enlightens the reasons for severe blindness
6. Research teams uncover risk genes for multiple sclerosis
7. Research shows NPD1 protects a key component of vision
8. Researchers find pathway that controls cell size and division
9. Researchers watch antibiotics, bacteria meet at atomic level
10. Researchers discover gene responsible for Restless Legs Syndrome
11. Research study describes the role part of the brain plays in memory

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/26/2017)... -- Securus Technologies, a leading provider of civil and ... corrections and monitoring, announces the appointment of a ... often, too many offenders return to jail or ... to tackle this ongoing problem and improve the ... significant steps are underway, Securus continues to invest ...
(Date:2/22/2017)... 2017 With the biometrics market to ... four technologies that innovative and agile startups must ... in the changing competitive landscape: multifactor authentication (MFA), ... "Companies can no longer afford to ... Dimitrios Pavlakis , Industry Analyst at ABI ...
(Date:2/21/2017)... LONDON , February 21, 2017 ... um 70 Millionen US-Dollar wachsen. Nach einem Gespräch mit mehr ... es einige Hindernisse zu überwinden gilt, um diese Prognose ... ... unter anderem die Mobilisierung der finanziellen Mittel für die ...
Breaking Biology News(10 mins):
(Date:3/27/2017)... MOSCOW , March 27, 2017 Infectex Ltd., a Russian ... Phase 2b-3 clinical study of SQ109 added to the standard drug therapy regimen in ... by scientists at Sequella, Inc. ( USA ) and the US National ... ... Maxwell Biotech Venture Fund Logo ...
(Date:3/27/2017)... -- Perthera,s Chief Bioinformatics Officer and research faculty member at ... will be speaking at the American Medical Informatics Association ... 2017, she will be speaking on the topic of ... Care" (from 10:30 a.m. – 12:00 p.m. PST) and ... participant in the "Making Precision Oncology Data More Usable ...
(Date:3/27/2017)... ... March 27, 2017 , ... PMG Research is pleased to announce ... by The Conference Forum in Boston on April 3-4, 2017. The CTC conference focuses ... trial outcomes and bring them closer to the patient. Clinical Trial Collaborations also will ...
(Date:3/27/2017)... 27, 2017  Trovagene, Inc. (NASDAQ: TROV), a precision ... Officer, Bill Welch , will be presenting at ... 9:00 AM EDT at the Essex House in ... Chief Scientific Officer, Mark Erlander , Ph.D., will ... conference.   The presentation will be webcast live ...
Breaking Biology Technology:
Cached News: